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1. Introduction 
Embryonic stem (ES) cells are derived from inner cell mass of blastocyst stage of fertilized eggs 
and remain undifferentiated in the presence of leukemia inhibitory factor (LIF) (Evans M.J & 
Kaufman M.H. (1981), Martin G.R. (1981).).  Depletion of LIF leads to ES cell to form 
embryoid body (EB) that can differentiate into several different lineage cells such as 
endodermal, mesodermal and ectodermal lineage cells.  Until now, ES cells have been induced 
to differentiate in vitro into several cell types such as hematopoietic cell (Nakano T.,et al. 
(1994), Nishikawa S.I.,et al. (1998), Palacios R.,et al. (1995).), pancreatic cell (Soria B.,et al. 
(2000).), neuronal cell (Brustle O.,et al. (1999), Scholer H.R.,et al. (1991).) and cardiomyocyte 
(Boheler K.R.,et al. (2002), Doetschman T.C.,et al. (1985), Klug M.G.,et al. (1996).).   
To be sure that ES cells are pluripotent, but mere transplantation of non-differentiated ES 
cells leads to teratomas as Yamamoto reported the teratoma formation after the 
transplantation of undifferentiated ES cells into retroperitoneum of nude mice (Yamamoto 
M.,et al. (2006).).  This is one of the main obstacles that limit the clinical application of ES cell 
transplantation therapy.  Therefore, it is essential to differentiate ES cells to some degree 
before transplantation.  But the information as to the directed differentiation of ES cells to 
kidney lineages are limited although spontaneous differentiation of ES cells to various cells 
is observed.  We have gathered pieces of information of the developmental biology and the 
differentiation conditions of several stem/progenitor cells to matured kidney. In this 
review, we focus on a dream of the generation of kidney from ES cells or stem/progenitor 
cells.   
2. Developmental biology of the kidney 
Mammalian kidney traces three successive stages during the development: pronephros, 
mesonephros and metanephros.  In mammals, pronephros, a rudimentary and temporary 
structure consisting of one nephron, retrogrades at the first stage of nephrogenesis.  Next, 
mesonephros arises as Wolffian duct from the intermediate mesoderm, elongates along the 
oral-caudal axis, and forms immature glomerular and tubular structures consisting of 
several dozens of nephrons.  However, both of the structures at this stage are not functional 
and then retrograde.  
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Metanephros develops from the caudal part of Wolffian duct and finally produces 
functional glomeruli and tubules as follows: A single ureteric bud emerges from the caudal 
part of the retrograding mesonephros and starts to branch.  Immature mesenchymal cells 
condense around the ureteric buds to form the metanephric blastema.  Cells around an each 
tip of the branching ureteric buds and another type of cells surrounding such cells are 
termed the metanephric mesenchyme and stromal cells, respectively.  The former 
metanephric mesenchymal cells differentiate through mesenchymal-to-epithelial 
transformation (MET) into various types of epithelial cells including visceral glomerular 
epithelial cells (podocytes), parietal glomerular epithelial cells, proximal tubular epithelial 
cells, and distal tubular epithelial cells, and develop into a cylindrical epithelial structure at 
an each tip of the ureteric buds.  At an end of the differentiating epithelial structures, 
podocytes and parietal glomerular epithelial cells interact with mesangial cells and 
fenestrated endothelial cells, and form globular networks of capillaries (glomeruli).  At the 
other end, the epithelial structures connect in a one-to-one manner to collecting ducts each 
of which is derived from one branch of the ureteric buds.  This whole structure is called the 
nephron, a unit to produce urine.  The final number of nephrons depends both on the 
number of branching of the ureteric buds and on the differentiation potentials of the 
metanephric mesenchyme independently.  In human, one kidney has one million nephrons. 
The interaction in a reciprocal and inductive manner between the metanephric mesenchyme 
and the ureteric bud plays an important role in the nephrogenesis.  A mouse or rat 
embryonic kidney further develops when placed in culture, but is not functional because 
vascular networks are not integrated.  In contrast, rat kidney rudiments at early stage of the 
development, which contain the metanephric mesenchyme and the ureteric bud, can form 
functional nephrons when it is transplanted in the omentum of other living animals 
(Hammerman M.R. (2004).).  These facts indicate that a set of the metanephric mesenchyme 
and the ureteric bud has the perfect intrinsic program to regulate immature cells, to recruit 
and integrate vascular components, and to form functional nephrons.   
3. Toward the regeneration of the kidney from ES cells 
3.1 Differentiation of rodent ES cells into renal lineage 
The kidney is a highly terminated and complex organ.  It needs to be formed so that the 
adjacent placement in three dimensions of several components of kidney cells are critical 
and only work when the placement is perfect unlike hematopoietic cells or insulin-secreting 
cells working as a cell itself.  In this section, we focus on the differentiation trials of murine 
ES cells into renal lineage.  Steenhard B.M. et al showed an integration of ES cells in 
metanephric kidney organ culture (Steenhard B.M.,et al. (2005).).  The authors microinjected 
murine ROSA26 ES cells that express ubiquitously β-galactosidase when cultured in the 
presence of LIF to suppress differentiation, into E12 or E13 metanephroi and kept them on 
organ culture system.  ES cell-derived, β-galactosidase-positive cells were found in epithelial 
structure resembling tubules and, on rare occasions, in structures resembling glomerular 
tufts.  By the analysis of electron microscopy, the ES cell-derived tubules were surrounded 
by basement membrane and had epithelial microvilli and junctional complexes.  Subset of 
these epithelial tubules expressed markers of Lotus tetragonolobus (LTA) and α1 Na+/K+ 
ATPase.  By infecting cytomegalovirus-promoter green fluorescent protein (GFP) 
adenovirus to ES cells before injection, injected ES cells were traced by GFP from 18h to 48h 
in cultured kidney, indicating that injected ES cells were definitely alive and functioning in 
the cultured kidney.   
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Kobayashi T. et al reported that Wnt4-transformed mouse ES cells differentiated into renal 
tubular cell in vitro and in vivo.  The authors stably transformed Wnt4 cDNA to mouse ES 
cells (Wnt4-ES cells) and incubated them by hanging drop culture method (Kobayashi T.,et 
al. (2005).).  Hepatocyte growth factor (HGF) and activin-A enhanced the expression of 
aquaporin (AQP)2 in Wnt4-ES cells and induced tubular-like structure formation in three 
dimensional culture.  The authors confirmed that the addition of anti-Wnt4 antibody in the 
culture system downregulated the frequency of tubular-like structure formation.  When 
Wnt4-ES cells were transplanted in the renal cortex of four-week-old mouse, they also 
formed tubular-like structure in teratoma.  The authors showed that embryoid bodies from 
the Wnt4-ES cells had an ability to differentiate into renal tubular cells.  The most significant 
point is that Wnt4 expressing ES cells can be integrated into tubular cells in the adolescent (4 
week old) kidney microenvironment which would be less suitable for ES cells to 
differentiate than in the microenvironment of E12 or E13 of kidney adopted by Steenhard.  
Wnt4, HGF and activin-A may be promoting factors for the differentiation of ES cells to 
renal tubular cells.  
Kim D.et al reported that mouse ES cells can differentiate into renal epithelial cells with the 
combination of retinoic acid, activin-A and Bone morphogenetic protein (Bmp)-7 ( Kim D. & 
Dressler G.R. (2005).).  The authors showed that cultured ES cells can be induced to express 
markers specific for the intermediate mesoderm with the combination of these three 
nephrigenic growth factors.  They also showed that treated ES cells can contribute to tubular 
epithelial cells with almost 100% efficacy by injecting into developmental kidney rudiments.  
The injected Rosa 26 ES cells were traced by lac-Z staining and the tubular cells were 
confirmed morphologically by immunohistochemical staining with LTA and laminin.  The 
transplantation or injection of cells entails a contentious problem of cell fusion although the 
authors insist that the occurrence of cell fusion in their experiment is very rare.  
Investigation of karyotype would be ideal for the detailed analysis. 
Vigneau C. et al used mosue ES cell line with GFP knocked into the functional brachyury 
locus as well as lacZ in the ROSA26 locus (LacZ/brachyury/GFP) in selection and lineage 
tracing (Vigneau C.,et al. (2007).).  The authors firstly optimized the culture conditions using 
activin-A to give rise to maximal numbers of renal progenitors identified by expression of 
the combination of renal markers, cadherin11, WT1, Pax2 and Wnt4.  Then, they next 
enriched LacZ/brachyury/GFP+ cells by FACS and injected these cells into embryonic 
kidney explants in organ culture.  Five days after the injection, β-galactosidase positive cells 
were incorporated into blastema of the nephrogenic zone.  Even after the single injection 
into developing live newborn mouse kidneys, the LacZ/brachyury/GFP+ cells were stably 
integrated into proximal tubules with normal morphology and normal polarization of 
alkaline phosphatase and AQP1 for 7 months without teratoma formation.  These results 
suggest that differentiation of ES cells with activin-A and selection for brachyury expression 
lead to the isolation and purification of renal proximal tubular progenitor cells.   
Bruce S.J. et al reported that ES cells can be differentiated into renal lineage using BMP4 in 
vitro (Bruce S.J.,et al. (2007).).  With their induction culture system, the authors confirmed 
that gene expressions of WT1, Wnt4, GDNF, Nephrin, mineral corticoid receptor, 
podocalyxin, Wnt11, Pod1 or AQP1 were upregulated at later stage.   
Ross E.A. et al reported a study of ES cells showing an importance of scaffolds (Ross E.A.,et 
al. (2009).).  The authors firstly decellularized intact rat kidney in a fashion that retained the 
matrix and secondly seeded them with pluriopotent rat ES cells either through the artery or 
through the ureter.  The transplanted cells populated and proliferated within the 
www.intechopen.com
 
Stem Cells in Clinic and Research 608 
glomerular, vascular and tubular structures.  The cells lost their original embryonic 
appearance and expressed differentiated immunohistochemical markers.  But the cells that 
lost the contact with basement membrane matrix became apoptotic.  This study suggests the 
importance of extracellular matrix for the kidney regeneration to occur as a scaffold.   
Morizane R. et al reported that differentiation of murine ES ells and iPS cells into renal 
lineage in vitro (Morizane R.,et al. (2009).).  By hanging drop of murine ES cells, renal 
inducing factors were screened.  GDNF and BMP7 enhanced the expression of Pax2 and 
WT1, markers of metanephric mesenchyme.  Activin enhanced the expression of Pax-2 and 
KSP, suggesting activin enhanced the differentiation of ES cells into not only to mesoderm 
but also to tubular cells.  According to their analysis, it is difficult to promote ES cells to 
differentiate into podocyte, because no inducer was found to enhance the expression of 
nephrin.  To be sure, their analysis is based on in vitro marker analysis only and 
morphogenic or functional analyses are lacking, but several differentiation markers are 
investigated to compare the differentiation of ES cells and iPS cells.  The information is 
useful to understand the effects of cytokines or growth factors for the designated 
differentiation of ES cells. 
Sall1, a multi-zinc finger transcription factor which is expressed at metanephric 
mesenchyme, is involved in mouse kidney organogenesis because Sall1-deficient mouse 
show kidney agenesis or severe dysgenesis (Nishinakamura R.,et al. (2001).).  It is highly 
expressed in ES cells and, most recently, it was reported to regulate ES cell differentiation in 
accordance with Nanog (Karantzali E.,et al. (2010).).  Sall1 inhibits the ectodermal and 
mesodermal differentiation.  More specifically, the induction of the gastrulation markers T 
brachyury, Goosecoid, and Dkk1 and the neuroectodermal markers Otx2 and Hand1 was 
inhibited by Sall1 overexpression during embryoid differentiation.  In consideration of the 
fact that kidney is derived from intermediate mesoderm, switching off at an appropriate 
timing the signal Sall1 once positive at an early stage of development would be important 
for the kidney organogenesis.  
Luis M. et al reported a method to isolate renal stem cells from embryonic kidney not from 
ES cells (Lusis M.,et al. (2010).).  Metanephric mesenchyme of the developing kidney gives 
rise to various types of epithelial cells including visceral glomerular epithelial cells 
(podocytes), parietal glomerular epithelial cells, proximal tubular epithelial cells, and distal 
tubular epithelial cells.  It is regarded as progenitor population pool of the developing 
kidney.  But isolated metanephric mesenchyme does not self renew and requires 
immortalization for survival in culture.  The authors developed a method of isolation and 
sustained culture of long-term repopulating, clonal progenitors from mouse embryonic 
kidney (E12.5) as free floating nephrospheres just as neurosphere often observed in neural 
stem cell culture system.  These cells showed clonal self renewal for more than twenty 
passages when cultured with bFGF and thrombin, showed broad mesodermal multipotency, 
but held the expression of renal transcription factors such as Wt1, Sall1, Eya1, Six1, Six2, 
Osr1 and Hoxa11.  These cells’ capacity to contribute to developing embryonic kidney was 
limited, and nephrospheres did not display in vitro renal epithelial capacity.  Holding 
mesodermal multipotency but renal transcription markers means that nephrosphere would 
be a developmentally transient state between pluripotent ES cells and renal progenitors.  
The nephrospheres can be cultured from Sall1-positive and –negative fraction of embryonic 
kidney, which suggests that they were derived from metanephric mesenchyme as a whole.  
This renal stem cell population could be cultured from only embryonic kidney, not from 
postnatal kidney. 
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3.2 Differentiation of human ES cells into renal lineage 
As to the human cells, there are only a few reports of differentiation of ES cells to renal 
lineage.  The concomitant use of retinoic acid, activin-A, and BMP-4 or BMP-7 induced the 
directed differentiation of human ES cells to renal precursors when analyzed by 
differentiation marker (Batchelder C.A.,et al. (2009).).  As to the culture substrate, gelatin 
was reported to most closely recapitulate the directed developmental pattern of renal gene 
expression.  Human ES cells also have an ability to differentiate into WT-1 and renin-
expressing cells with the combination of several growth factors including either nerve 
growth factors (NGF) or HGF (Schuldiner M.,et al. (2000).).  Tarantal A.F. et al reported an 
imaging study of human ES cells (Tarantal A.F.,et al. (2011).).  The authors radiolabeled 
human ES cells expressing firefly luciferase, transplanted them to fetal monkey kidney at 
early second trimester under ultrasound guidance, and traced them by non-invasive 
imaging (positron emission tomography (PET) and bioluminescence imaging (BLI)).  
Transplanted cells were imaged in vivo and identified at the site of injection.  Lin et al 
reported an isolation method by flow cytometer of putative renal progenitor fraction of 
human ES cells (Lin S.A.,et al. (2010).).  The authors reduced serum concentration and feeder 
cell density to differentiate human ES cells in vitro for 14 days.  Then they fractioned the 
differentiated ES cells based on the expression marker CD24, podocalyxin and GCTM2.  
These cells upregulated the renal transcription factor, PAX2, LHX1 and WT1 compared to 
unfractionated ES cells.  Immunohistochemical analysis also confirmed these cells 
coexpressed nuclear factor WT1 and PAX2 protein.  Microarray analysis showed that the 
most differentially up-regulated genes in the fraction were associated with kidney 
development compared to other fractions.   
3.3 Lessons from animal cap study 
The differentiation conditions of murine or human ES cells to renal lineage are similar to the 
developmental biology in amphibians.  In amphibian eggs, the ectodermal cell mass of mid-
blastula embryos, what is celled “animal cap”, is similar to ES and iPS cells in mammals.  
When animal caps are treated with the combination of retinoic acid and activin-A, they 
differentiated into pronephric tubules (Osafune K.,et al. (2002).).  Using this in vitro system 
to generate pronephros, the marker gene expression for pronephric tubules were observed 
(Brennan H.C.,et al. (1999).) and the molecular mechanism underlying pronephros 
development was investigated.  These differentiation-inducing factors, retinoic acid and 
activin-A have been applied to directed differentiation trials of ES cells to renal lineage.   
3.4 ES cells and kidney stem/progenitor cells 
In consideration of these previous reports as to the differentiation of ES cells to renal 
lineage, the information is limited and we have to learn the microenvironment from 
signaling during the embryonic development as an early stage of differentiation and from 
transdifferentiation or conversion condition from other precursor and/or stem cells to the 
renal lineage as a late stage of development.  In general, stem/progenitor cells and the 
proper microenvironment are essential for the repair or regeneration of damaged tissue.  
The same is true to the ES cell for the directed differentiation.  A suitable microenvironment 
includes the presence of local cytokines as well as of extracellular matrix which can function 
as a scaffold and give rise to cytokines or growth factors around the stem/progenitor cell.  
Micro RNA coated with microvesicle which is discussed later would be added.   
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3.5 Lessons from the repair of kidney by non-ES cells 
In thinking of the natural development of ES cells into cells of the kidney, ES cells would 
develop into component cells of the kidney via renal stem/progenitor cells (pathway II in 
fig 1).  Or, ES cells may develop into component cells of the kidney without going through 
renal stem/progenitor cells (pathway I in fig 1).  But renal stem/progenitor cells can give 
rise to all component cells of the organ, developing ES cells into renal stem/progenitor cells 
would be the most efficient way to create component cells of the kidney.  We have focused 
on the renal stem/progenitor cell for the regeneration or repair, and ES cell is one of the 
promising candidates apart from the ethical problem.  Let us first overview the repair of 
kidney by the stem/progenitor cell other than ES cells, and then try to find out the clue to 
manipulate the ES cells to the renal lineage. 
As an extra-renal source of the kidney stem/progenitor cell, bone marrow cells or other cells 
(Wang Y.,et al. (2004).) have been investigated.  In the early 2000s, pluripotent bone marrow-
derived stem cells were thought to contribute to kidney repair.  Bone marrow comprises 
several cell types such as endothelial progenitor cells, hematopoietic stem cells (HSCs), and 
mesenchymal stromal cells (MSCs) which is often referred to as mesenchymal stem cells.  
Bone marrow-derived stem cells appeared to be able to replace damaged renal tissue by 
replacing mesangial cells (Imasawa T., et al. (2001), Ito T.,et al. (2001).), tubular epithelia 
cells (Poulsom R.,et al. (2001).), endothelial cells (Rookmaaker M.B.,et al. (2003).) and even 
podocytes (Prodromidi E.I., et al. (2006), Sugimoto H.,et al. (2006).).  But these researches 
were based on the transplantation method and the kidney specific marker analysis.  
Therefore, an event of cell fusion appears to represent a part of the engraftment of the 
recipient cells by the donor cells which was interpreted as transdifferentiation in the 
publication of that era.  In a strict meaning, the transdifferentiation is conversion from one 
cell lineage to another different lineage with conversion of cellular functions and markers 
and maintenance of a normal karyotype.  In studies of these periods, the concept of 
transdifferentiation was loosely defined and clear transdifferentiation was not demonstrated 
in many of the studies.  In thinking of the ES cell differentiation via extrarenal cells into 
renal lineage (pathway III or IV in Fig 1), these in vivo transplantation studies seem helpful, 
however, they should be interpreted with caution.  In vitro differentiation condition from 
extrarenal source into renal component cells (Suzuki A.,et al. (2004).) may be helpful in 
manipulating ES cells into renal lineage.  As to the cell fusion, Bonde S. et al recently 
reported an interesting research.  When bone marrow cells are cocultured with ES cells, the 
phenomenon of cell fusion occurs.  Almost all the hybrid cells had lost CD45 expression.  In 
short, after cell fusion, the ES cells can reprogram the cellular contents of somatic cells (bone 
marrow cells in this research) to adopt an ES cell phenotype.   
Bone marrow-derived pluripotent MSCs, but not HSCs have an ability to engraft to tubular 
epithelial cells in an experimental kidney injury model and to help to recover the lost renal 
function (Morigi M.,et al. (2004).).  It has recently been reported that kidney-derived MSC 
contribute to vasculogenesis, angiogenesis, and endothelial repair (Chen J.,et al. (2008).).  
This finding supports the possibility that MSC residing in kidney can participate in kidney 
repair or regeneration. 
But recent studies argue against the direct differentiation of bone marrow-derived stem cells 
or MSC into kidney.  The relatively small frequency of engraftment of bone marrow-derived 
cells (3-22%) means that most of the kidney component cells are composed of kidney 
resident cells.  Moreover the functional improvement in the recipient transplanted with 
stem/progenitor cells is not due to the existence of transplanted cell itself in the kidney.  For 
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example, after ischemia-reperfusion injury, recipients transplanted with MSC keep 
improved renal function in spite of the small percentage of engraftment by the donor cells.  
This may be due to the various cytokines secreted from transplanted MSC that organize an 
appropriate microenvironment for the kidney repair in autocrine and paracrine fashion.  To 
be sure, MSC secretes various cytokines such as VEGF, HGF and IGF-1 (Togel F.,et al. 
(2005).).  Injection of bone marrow-derived MSC into peritoneal cavity attenuated the 
cisplatin-induced renal failure without the engraftment of MSC in the kidney.  The 
conditioned media from culture of these stromal cells induced migration and proliferation 
of kidney-derived epithelial cells and significantly diminished cisplatin-induced proximal 
tubule cell death (Bi B.,et al. (2007).).  In considering the cell administration pathway, the 
finding from these two experiments indicates that it is the humoral factors, not cellular 
factors that contribute to the kidney repair or regeneration by MSC.   
3.6 Humoral factors important for the kidney repair or regeneration 
Then the next question is “what are the humoral factors important for the kidney repair or 
regeneration?”  Many factors have been proposed as candidates.  One candidate is various 
cytokines secreted by MSC.  There is a report indicating that administration of MSC to a rat 
model of ischemia-reperfusion-induced acute renal failure improved renal function, 
whereas administration of syngeneic fibroblasts did not.  MSC expressed more growth 
factors VEGF, HGF and IGF-1 than fibroblasts ( Togel F., et al (2005)).  Some of these factors 
are known to modulate kidney function or repair.  For example, VEGF attenuates 
glomerular inflammation and accelerates glomerular capillary repair (Shimizu A.,et al. 
(2004).).  HGF, an angiogenic growth factor, prevents epithelial cell death and enhances 
regeneration and remodeling of injured or fibrotic renal tissue ( Matsumoto K. & Nakamura 
T. (2001).).  The effect of these growth factors or cytokines is evaluated as individual effect.  
If these factors are mixed and administered at a time, or if the administration timing is 
sequential, the effect might be different and complicated.  Understanding the 
microenvironment in which the stem/progenitor cells is put in time and space in terms of 
cytokine expression would be firstly vital.  This is the point from protein expression level.   
Another humoral candidate factor would be RNA in microvesicle.  This is a newly proved 
communication system.  Microvesicles derived from MSC activate the proliferation of 
surviving renal tubular cells after injury by transferring mRNA (Bruno S.,et al. (2009).).  
Thus, MCS can repair the damaged tubuli by secreting microvesicles which function in a 
paracrine fashion.  This is a communication tool in nucleotide level whose regulation system 
is not well known.  Moreover, a microRNA are reported to mediate transforming growth 
factor-β1 autoregulation in renal glomerular mesangial cells (Kato M.,et al. (in press).).  Ho J. 
et al reported that the loss of microRNAs in nephron progenitors resulted in a premature 
depletion of the population during kidney development, and as a consequence, a marked 
decrease in nephron number, which was accompanied by the increased apoptosis and 
expression of the pro-apoptotic protein Bim (Ho J.,et al. (in press).).  Expression profiling in 
the embryonic kidney revealed several microRNAs (mmu-miR-10a, mmu-miR-17-5p and 
mmu-miR-106b) that are expressed in nephron progenitors and that are thought to target 
Bim transcript.  MicroRNA-mediated regulation of Bim expression affects nephron survival.  
The importance of RNA is not restricted to only nephrogenesis.  Recently, non-coding RNA 
has been emerging as key regulators of embryogenesis in general.  Transcription factors 
OCT4 and NR2F2 and microRNA miR-302 are linked in the regulatory circuitry that 
critically regulate both pluripotency and differentiation in human ES cells (Rosa A. & 
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Brivanlou A.H. (2011).).  The understanding of the microenvironment in terms of nucleotide 
level, microRNA during embryogenesis including nephrogenensis is important and the 
research has just begun.   
Then, the last question would be “what are the cellular targets of these humoral factors?”  
The answer would be definitely the renal stem/progenitor cells including ES cells.  Many 
researchers have undertaken this challenging theme to get the clearly defined renal 
stem/progenitor cells.  Based on the characteristics of slow cycling property of 
stem/progenitor cells, the renal stem cell has been reported to exist as a label-retaining cell 
in renal papilla (Oliver J.A.,et al. (2004).) or tubular epithelial cells (Maeshima A.,et al. 
(2003).).  Bowman’s capsule (Sagrinati C.,et al. (2006).) and the S3 segment of the proximal 
tubules (Kitamura S.,et al. (2005).) have also been reported to contain renal stem/progenitor 
cells.  A fraction of CD133+ CD24+ cells within the population of parietal epithelial cells are 
reported to engraft to tubular cells (Sagrinati C. (2006).).  As markers of renal 
stem/progenitor cells are not clear, side population (SP) phenotype was adopted as a tool to 
investigate stem/progenitor cells in the kidney.  Under our experimental conditions, 
kidney-derived side population cells did not engraft to kidney component cells (Iwatani 
H.,et al. (2004).), while other researchers reported the cells differentiated into multiple 
lineages in vitro and the transplantation of these cells in vivo ameliorated the impaired renal 
function without apparent integration into kidney component cells (Challen G.A.,et al. 
(2006).).  Induction of ES cells into the above mentioned candidates of kidney 
stem/progenitor cells might be a target of the future study (pathway II-a in Fig 1). 
3.7 Epigenetic factors important for the kidney repair or regeneration 
A proliferative potential of the kidney is much lower than that of epithelial cells of the 
intestine.  The characteristics of kidney are also borne out by the incidence of malignant 
tumors, as the kidney is less likely to be the origin of a tumor than is the gastrointestinal 
tract.  The less proliferative potential of the kidney may be due to gene programming of its 
constituent cells.  More precisely, partial and programmed gene inactivation of genomic 
DNA that is controlled in time and space, may be involved in the regulation of kidney fate.  
Different gene expressions in different organs for all the same genome: this mysterious but 
important fact cannot be solved without the concept of organ specific gene activation or 
inactivation.  The system of epigenetic regulation could explain the concept.  Actually, the 
epigenetic regulations are thought to be important for developmental biology.  In terms of 
the renal progenitor cells, de Groh E.D. et al reported an interesting investigation (de Groh 
E.D.,et al. (2010).).  The authors found that the treatment with 4-(phenylthio)butanoic acid 
(PTBA), which functions as histone deacetylase (HDAC) inhibitor expanded the renal 
progenitor cells in zebrafish.  The PTBA-mediated expansion of renal progenitor cells was 
involved in retinoic acid signaling.  Finally, the authors suggest a mechanistic link between 
renal progenitor cells, HDAC and the retinoic acid signaling pathway, although the precise 
target of HDAC is not clarified.   
Aiden A.P. et al reported a comparison of genome-wide chromatin profiles of Wilms 
tumors, ES cells and normal kidney (Aiden A.P.,et al. (2010).).  Wilms tumor is a pediatric 
cancer, characterized by a triphasic histology that includes undifferentiated blastemal 
components and varying amounts of epithelial and stromal elements (Rivera M.N. & Haber 
D.A. (2005).).  The tumor can be associated with developmental abnormalities of 
nephrogenic rest and thought to be closely related to kidney organogenesis.  Wilms tumor 
exhibited active chromatin domains previously observed in ES cells in terms of epigenetic 
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state.  In the tumor cells, the domains often correspond to the genes that are critical for renal 
development and are expressed in renal stem cells.  Wilms tumor cells also expressed 
“embryonic” chromatin regulators and maintained stem cell-like p16 silencing.  It is 
suggested that Wilms tumor cells share transcriptional and epigenetic characteristics with 
normal renal stem cells  As the developmental biology of the kidney is closely related to 
epigenetic state, the investigation of the mechanism of the epigenetic regulation of 
pluripotent stem cells would be highlighted.   
In terms of the current difficulty in making many homogenous, high quality iPS cells 
available due to the lack of quality checking system, ES cell would be the best target for the 
development of the induction or differentiation conditions for pluripotent stem cells to the 
renal lineage.  ES cell study will strongly lead iPS cell study and make the iPS cell study 
more matured.   
 
 
Fig. 1. Possible pathways for ES cells to differentiate into renal lineage 
There may be several pathways for ES cells to differentiate into renal lineage.   
ES cells would develop into component cells of the kidney via renal stem/progenitor cells 
(pathway II-a and II-b). Or, ES cells may develop into component cells of the kidney without 
going through renal stem/progenitor cells (pathway I), although the differentiation 
condition into kidney from ES cell is not clarified yet.  Thick arrow (pathway II-a and II-b) 
would be the putative mainstream of ES cell differentiation.  Previous reports of pathway IV 
may be helpful in understanding pathway II-b.  
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